| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $433.96 ▲ +0.82% | Yesterday | $434.31 ▼ -0.89% | Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $430.44 and targets $433.96 (+0.82%). The near-term read is upside; watch $435.73 / $421.83 because daily realized volatility is about 1.28%. |
Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $430.44 and targets $433.96 (+0.82%). The near-term read is upside; watch $435.73 / $421.83 because daily realized volatility is about 1.28%. | ||||
| Week | $427.01 ▼ -0.80% | Last Week | $450.41 ▼ -4.43% | The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $450.41 to $427.01 (-0.80%). It gives downside momentum context for this stock, so breaks around $435.73 / $421.83 matter more than a single tick. |
The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $450.41 to $427.01 (-0.80%). It gives downside momentum context for this stock, so breaks around $435.73 / $421.83 matter more than a single tick. | ||||
| Month | $416.13 ▼ -3.32% | Last Month | $436.59 ▼ -1.41% | The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-3.32%), compared with the live reference near $430.44. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-3.32%), compared with the live reference near $430.44. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $400.49 ▼ -6.96% | Last Year | $435.32 ▼ -1.12% | The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $400.49 (-6.96%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $400.49 (-6.96%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $363.56 ▼ -15.54% | 5 Years Ago | $213.43 ▲ +101.68% | The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $363.56 (-15.54%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $363.56 (-15.54%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 86.5 | Bullish |
| MACD | 0.02 | Neutral |
| SMA 50 | $432.04 | Below |
| SMA 200 | $408.62 | Above |
| EMA 20 | $393.22 | Above |
| Opening Price | $434.31 | Start Date | 2020-01-02 |
| Day Range | $427.64 – $439.98 | Market Cap | $111.09B |
| Monthly Range | $423.24 – $453.06 | 24h Volume | n/a |
| 90D Range | $423.24 – $499.17 | Circulating | n/a |
| 52W Range | $366.54 – $513.76 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.